Malignant focal liver lesions |
|
|
|
|
Hepatocellular carcinoma |
Hyperechoic |
Isoechoic |
Hypo- or isoechoic (30%) |
Hypoechoic |
Metastases |
Hypo- or hyperechoic (hypervascular) |
Hypoechoic with or without rim enhancement |
Hypoechoic |
Hypoechoic |
Cholangiocarcinoma |
Hypo- or hyperechoic (15%) |
Iso- or hypoechoic |
Hypoechoic |
Hypoechoic |
Benign focal liver lesions |
Regenerating nodules |
Iso- or hypoechoic |
Isoechoic |
Isoechoic |
Isoechoic |
Dysplastic nodules |
Hyper, iso- or hypoechoic |
Isoechoic |
Hypo- or isoechoic |
Hypo- or isoechoic |
Hemangiomas |
Hyperechoic (peripheral nodular enhancement) |
Centripetal filling |
Isoechoic if filling is complete (intralesional hypoechoic areas in 50%) |
Isoechoic (intralesional hypo-echoic areas in 50%) |
Homogenous hyperechoic in 20% of small hemangiomas |
Hyper- or isoechoic |
Hyper- or isoechoic |
Isoechoic |
Focal nodular hyperplasia |
Hyperechoic |
Hyper- or isoechoic; non-enhancing central scar in 45% |
Hyper- or isoechoic; non-enhancing central scar in 45% |
Hyper- or isoechoic |
Hepatocellular adenoma |
Hyperechoic |
Isoechoic |
Isoechoic |
Isoechoic |
Fatty changes or focal fatty sparing |
Isoechoic |
Isoechoic |
Isoechoic |
Isoechoic |
Noncomplicated cysts |
Absence of enhancement |
Absence of enhancement |
Absence of enhancement |
Absence of enhancement |